Clinical Trial Update: Effectiveness of the Early Addition of Abacavir to an Anti-HIV Drug Combination [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the effectiveness of early addition of abacavir to an HIV drug regimen; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Ziagen (Abacavir)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED